Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI Gains 7%; BSE HEALTHCARE Index Down 0.3%
Tue, 1 Oct 13:25

AMBALAL SARABHAI Gains 7%; BSE HEALTHCARE Index Down 0.3%Image source: DNY59/www.istockphoto.com

AMBALAL SARABHAI share price has zoomed 7% and is presently trading at Rs 58.3.

Meanwhile, the BSE HEALTHCARE index is at 44,095.2 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 6.5%) and GRANULES INDIA (up 3.7%).

Aurobindo Pharma (down 2.1%) and Pfizer (down 2.1%) are among the top losers today.

Over the last one year, AMBALAL SARABHAI has moved up from Rs 37.9 to Rs 58.3, registering a gain of Rs 20.3 (up 53.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,071.8 to 44,095.2, registering a gain of 57.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 170.7%), SUVEN PHARMACEUTICALS (up 125.3%) and Glenmark Pharma (up 114.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 84,249.8 (down 0.1%).

The top losers among the BSE Sensex today are Indusind Bank (down 2.0%) and Asian Paints (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..

In the meantime, NSE Nifty is at 25,771.1 (down 0.2%). Indusind Bank and Asian Paints are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,118.7 to 84,249.8, registering a gain of 18,131.1 points (up 27.4%).

AMBALAL SARABHAI Financial Update...

AMBALAL SARABHAI net profit grew 118.2% YoY to Rs 7 million for the quarter ended June 2024, compared to a loss of Rs 39 million a year ago. Net sales rose 12.7% to Rs 407 million during the period as against Rs 361 million in April-June 2023.

For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.

The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 34.3.


Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 7%; BSE HEALTHCARE Index Down 0.3%". Click here!